Piramal Enterprises arm acquires UK-based Abacus International
The acquisition will result in a significant global expansion of Decision Resources Group's market access capabilities, Piramal Enterprises today said in a statement.
"Abacus in an important acquisition in Decision Resources Group's (DRG) overall strategy to expand our market access capabilities and offer our clients the most innovative, high-value advisory solutions," DRG CEO Peter Hoengsberg said, adding it would boost the company's position in Europe as in important resource for healthcare firms worldwide.
Abacus will be a part of the market access business unit at Decision Resources Group (DRG) which currently includes the brands, Fingertip Formulary, HealthLeader-InterStudy, PharmaStrat and Pinsonault, the company said.
Commenting on the acquisition, DRG President – Market Access Business Unit Jim Lang said: "Besides expanding our global market access services and products, the acquisition also allows us to now offer market access capabilities for the medical device and industry-leading mobile communication tools."
Abacus International CEO Simon Howard said the deal would help the firm in becoming a fully integrated global market access solutions provider.
The company will continue to be headquartered in Bicester, England, the statement added.
In May this year, Piramal Enterprise had announced acquisition of US-based firm Decision Resources Group for a consideration of nearly USD 635 million (Rs 3,400 crore) to boost research and development.
Scrips of Piramal Enterprises were trading at Rs 494 per share during the afternoon trade, up 0.28 per cent from the previous
Be the first to comment.